Cognitive-affective manifestations since premanifest phases of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease

被引:1
|
作者
Bolzan, Gabriela [1 ,2 ]
Eyng, Maria E. Mueller [3 ]
Leotti, Vanessa B. [4 ,5 ]
Saraiva-Pereira, Maria L. [1 ,6 ,7 ]
Jardim, Laura B. [1 ,6 ,8 ,9 ]
机构
[1] Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, Brazil
[2] Hosp Clin Porto Alegre, Ctr Pesquisa Clin & Expt, Porto Alegre, Brazil
[3] Univ Fed Rio Grande do Sul, Fac Med, Porto Alegre, Brazil
[4] Univ Fed Rio Grande do Sul, Dept Estat, Porto Alegre, Brazil
[5] Univ Fed Rio Grande do Sul, Programa Posgrad Epidemiol, Porto Alegre, Brazil
[6] Hosp Clin Porto Alegre, Serv Genet Med, Rua Ramiro Barcelos 2350, BR-90035003 Porto Alegre, Brazil
[7] Univ Fed Rio Grande do Sul, Dept Bioquim, Porto Alegre, Brazil
[8] Univ Fed Rio Grande do Sul, Dept Med Interna, Porto Alegre, Brazil
[9] Hosp Clin Porto Alegre, DMI FAMED UFRGS, Rua Ramiro Barcelos 2350, BR-90035003 Porto Alegre, Brazil
关键词
Cerebellar Cognitive Affective; Schmahmann Syndrome; Spinocerebellar Ataxia Type 3; Machado-Joseph Disease; Cognition; Affect; MACHADO-JOSEPH-DISEASE; NEUROPATHOLOGY; DYSFUNCTION; SCALE; MIND;
D O I
10.1016/j.cortex.2023.09.021
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Background: Cognitive deficits were related to Spinocerebellar Ataxia type 3/MachadoJoseph Disease (SCA3/MJD), but the Cerebellar Cognitive Affective Syndrome (CCAS) needs further investigation in this disorder. We aimed to characterize cognitive-affective deficits in manifest and premanifest SCA3/MJD carriers.Methods: Subjects at 50% risk, manifest carriers and unrelated controls were evaluated inperson or in virtual settings with CCAS Scale (CCAS-S), Stroop Color-Word Test (SCWT), Trail-Making Test (TMT), and Reading the Mind in the Eyes Test (RMET). Scale for Assessment and Rating of Ataxia (SARA) >2.5 or Friedreich Ataxia Rating Scale/Activities of Daily Living (FARS-adl) >4 divided carriers into manifest and premanifest. Time after onset or time left to gait ataxia onset (TimeToAfterOnset) were estimated. Differences between groups and correlations with TimeToAfterOnset, SARA and FARS-adl were checked.Results: After random selection to balance groups, 23 manifest and 35 premanifest carriers, and 58 controls were included. CCAS-S, semantic fluency, phonemic fluency, category switching, affect, SCWT, and RMET showed significant differences between manifest carriers and controls; premanifest carriers mostly displayed intermediate values between controls and manifest carriers. These variables correlated with TimeToAfterOnset and SARA scores of the carriers. Correlations with SARA were stronger in the pre-ataxic group. CCAS-S had the strongest correlations with time and SARA. Discussion: Cognitive-affective deficits in SCA3/MJD involve executive function, language, affect, and social cognition, which seem to be altered prior to the ataxia onset, and correlate with markers of motor progression. CCAS-S was the most promising biomarker and should be evaluated in longitudinal studies.(c) 2023 Elsevier Ltd. All rights reserved.
引用
收藏
页码:370 / 382
页数:13
相关论文
共 50 条
  • [31] Machado-Joseph disease/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy
    Matos, Carlos A.
    de Almeida, Luis Pereira
    Nobrega, Clevio
    JOURNAL OF NEUROCHEMISTRY, 2019, 148 (01) : 8 - 28
  • [32] Eye Movement Abnormalities in patients with Spinocerebellar ataxia 3/Machado-Joseph disease
    Ghasia, Fatema Firoz
    Wilmot, George
    Ahmed, Anwar
    Shaikh, Aasef
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [33] Spinocerebellar ataxia type 3/Machado-Joseph disease manifested as spastic paraplegia: A clinical and genetic study
    Song, Yanmin
    Liu, Yunhai
    Zhang, Ning
    Long, Lili
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 9 (02) : 417 - 420
  • [34] Clinical course of the patients with spinocerebellar ataxia type 3/Machado-Joseph disease in the Hokuriku district in Japan
    Ishida, C.
    Motozaki, Y.
    Takahashi, K.
    Ikeda, T.
    Asakawa, M.
    Komai, K.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 305 - 306
  • [35] Prenatal diagnosis of spinocerebellar ataxia type 3/Machado-Joseph disease in mainland China A case report
    Lei, Lifang
    Wang, Junling
    Zhang, Shen
    Jiang, Hong
    Shen, Lu
    Xu, Qian
    Yan, Xinxiang
    Yuan, Yi
    Pan, Qian
    Xia, Kun
    Tang, Beisha
    NEURAL REGENERATION RESEARCH, 2011, 6 (26) : 2047 - 2049
  • [36] Devastation of the lateral reticular and external cuneate nuclei in spinocerebellar ataxia type 3 (Machado-Joseph disease)
    Rüb, U
    de Vos, RAI
    Brunt, ER
    Schultz, C
    Paulson, H
    Braak, H
    ACTA NEUROPATHOLOGICA, 2002, 104 (05) : 567 - 567
  • [37] Absence of spinocerebellar ataxia type 3/Machado-Joseph disease within ataxic patients in the Czech population
    Bauer, PO
    Zumrova, A
    Matoska, V
    Marikova, T
    Krilova, S
    Boday, A
    Singh, B
    Goetz, P
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 (11) : 851 - 857
  • [38] Presumed rapid eye movement behavior disorder in Machado-Joseph disease (spinocerebellar ataxia type 3)
    Friedman, JH
    MOVEMENT DISORDERS, 2002, 17 (06) : 1350 - 1353
  • [39] MACHADO-JOSEPH DISEASE IS NOT AN ALLELE OF THE SPINOCEREBELLAR ATAXIA-2 LOCUS
    TWIST, EC
    FARRER, LA
    MACLEOD, PM
    RADVANY, J
    CHAMBERLAIN, S
    ROSENBERG, RN
    ROULEAU, GA
    HUMAN GENETICS, 1994, 93 (03) : 335 - 338
  • [40] Quantitative susceptibility mapping in spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD)
    Xie, Fangfang
    Liao Weihua
    Ouyang Lirong
    Wang, Xiaoyi
    Xing, Wu
    ACTA RADIOLOGICA, 2020, 61 (04) : 520 - 527